These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6464996)

  • 1. Bretylium tosylate in patients with acute myocardial infarction.
    Torresani J
    Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
    Puddu PE; Jouve R; Saadjian A; Torresani J
    J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug].
    Dłuzniewski M
    Pol Tyg Lek; 1988 Oct; 43(44):1415-8. PubMed ID: 3075282
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction].
    Kochmański M; Rdzanek H; Zochowski RJ
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; Pickron J; Goldman AM
    Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bretylium tosylate--induced stabilization of electrical systole duration in patients with acute myocardial infarction.
    Jouve R; Puddu PE; Torresani J
    Heart Lung; 1982; 11(5):399-405. PubMed ID: 6921188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life threatening ventricular dysrhythmias: intervention with bretylium tosylate.
    Sullivan HE; Wehner RJ
    AANA J; 1983 Jun; 51(3):284-9. PubMed ID: 6613506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of prophylactic bretylium in preventing ventricular fibrillation complication acute myocardial infarction.
    Heart Lung; 1980; 9(5):910-1. PubMed ID: 6904422
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
    Slack JD; Rizk AE; Wright KE
    Heart Lung; 1979; 8(4):721-7. PubMed ID: 378903
    [No Abstract]   [Full Text] [Related]  

  • 11. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E; Gibson JK
    Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of bretylium to suppress inducible ventricular tachycardia.
    Greene HL; Werner JA; Gross BW; Sears GK
    Am Heart J; 1983 May; 105(5):717-21. PubMed ID: 6846114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bretylium tosylate: a review.
    Bryan CK; Darby MH
    Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
    Patterson E; Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1981 Mar; 216(3):453-8. PubMed ID: 7205624
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylaxis and therapy of ventricular fibrillation: bretylium reviewed and lidocaine refuted.
    Bacaner M
    Int J Cardiol; 1983 Sep; 4(2):133-52. PubMed ID: 6354941
    [No Abstract]   [Full Text] [Related]  

  • 17. Bretylium tosylate in prevention of cardiac dysrhythmias after myocardial infarction.
    Taylor SH; Saxton C; Davies PS; Stoker JB
    Br Heart J; 1970 May; 32(3):326-9. PubMed ID: 4911756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experiences with bretylium tosylate].
    Steffen V; Assmann I; Fiehring H
    Z Gesamte Inn Med; 1976 Sep; 31(17):684-8. PubMed ID: 793213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.